The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Robust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Lung cancer: current therapies and new targeted treatments
Hirsch, F. R., Scagliotti, G. V., Mulshine, J. L., Kwon, R., Curran, W. J., Wu, Y.-L., & Paz-Ares, L. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30958-8 · Cited by 3,283
Schadendorf, D., Hodi, F. S., Robert, C., Weber, J. S., Margolin, K., Hamid, O., Patt, D., Chen, T.-T., Berman, D. M., & Wolchok, J. D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2736 · Cited by 2,141
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014) · Cancers · doi:10.3390/cancers6031670 · Cited by 1,538
Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,447
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Gu-Trantien, C., Loi, S., Garaud, S., Equeter, C., Libin, M., de Wind, A., Ravoet, M., Le Buanec, H., Sibille, C., Manfouo-Foutsop, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67428 · Cited by 1,070
Alberg, A. J., Brock, M. V., Ford, J. G., Samet, J. M., & Spivack, S. D. (2013) · Chest · doi:10.1378/chest.12-2345 · Cited by 737
Candido, J., & Hagemann, T. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9847-0 · Cited by 653
Ali, H. R., Chlon, L., Pharoah, P. D. P., Markowetz, F., & Caldas, C. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002194 · Cited by 615
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
Al-Shibli, K. I., Donnem, T., Al-Saad, S., Persson, M., Bremnes, R. M., & Busund, L.-T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 614
Bremnes, R. M., Busund, L.-T., Kilvær, T. L., Andersen, S., Richardsen, E., Paulsen, E. E., Hald, S., Khanehkenari, M. R., Cooper, W. A., Kao, S. C., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.01.015 · Cited by 502
Petersen, R. P., Campa, M. J., Sperlazza, J., Conlon, D., Joshi, M., Harpole, D. H., & Patz, E. F. (2006) · Cancer · doi:10.1002/cncr.22282 · Cited by 433
The concept of immune surveillance against tumors: The first theories
Ribatti, D. (2017) · Oncotarget · doi:10.18632/oncotarget.12739 · Cited by 332
Memory B Cells of Mice and Humans
Weisel, F., & Shlomchik, M. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055531 · Cited by 307
Diverse macrophages polarization in tumor microenvironment
Rhee, I. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0820-y · Cited by 290
Immune targets and neoantigens for cancer immunotherapy and precision medicine
Wang, R.-F., & Wang, H. Y. (2017) · Cell Research · doi:10.1038/cr.2016.155 · Cited by 225
T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An Overview
Ivanova, E. A., & Orekhov, A. N. (2015) · BioMed Research International · doi:10.1155/2015/327470 · Cited by 166
Immunotherapy Comes of Age in Lung Cancer
Khanna, P., Blais, N., Gaudreau, P.-O., & Corrales, L. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.06.006 · Cited by 100
Inoshima, N., Nakanishi, Y., Minami, T., Izumi, M., Takayama, K., Yoshino, I., & Hara, N. (2002) · PubMed · Cited by 99
Kurebayashi, Y., Emoto, K., Hayashi, Y., Kamiyama, I., Ohtsuka, T., Asamura, H., & Sakamoto, M. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0214 · Cited by 92
Timperi, E., Pacella, I., Schinzari, V., Focaccetti, C., Sacco, L., Farelli, F., Caronna, R., Bene, G. D., Longo, F., Ciardi, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1175800 · Cited by 86
The emerging role of myeloid-derived suppressor cells in lung diseases
Kolahian, S., Öz, H. H., Zhou, B., Griessinger, C. M., Rieber, N. P., & Hartl, D. (2016) · European Respiratory Journal · doi:10.1183/13993003.01572-2015 · Cited by 80
Development of T follicular helper cells and their role in disease and immune system
Eivazi, S., Bagheri, S., Hashemzadeh, M. S., Ghalavand, M., Qamsari, E. S., Dorostkar, R., & Yasemi, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.083 · Cited by 76
Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes
Faghih, Z. S., Erfani, N., Haghshenas, M. R., Safaei, A., Talei, A., & Ghaderi, A. A. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.11.021 · Cited by 74
Mechanisms of immune response regulation in lung cancer.
Domagala-Kulawik, J. J., Osińska, I., & Hoser, G. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2013.11.03 · Cited by 73
Regulatory T cells and potential inmmunotherapeutic targets in lung cancer
Zhang, D., Chen, Z., Wang, D. C., & Wang, X. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9566-0 · Cited by 43
Precision medicine in immune checkpoint blockade therapy for non‐small cell lung cancer
Liu, X., & Cho, W. C. S. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0136-7 · Cited by 41
Self-citationImmune checkpoint inhibitors in first-line therapy of advanced non-small cell lung cancer
Remón, J., & Besse, B. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000351 · Cited by 34
Zhang, Y., Ma, C., Wang, M.-M., Hou, H., Cui, L., Jiang, C., Sun, J., & Qu, X. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1553-6 · Cited by 26
Lung cancer in 2016: immunotherapy comes of age
Mitchell, P. L. R., & John, T. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30379-4 · Cited by 14
Cited by
Tumour-associated neutrophils in patients with cancer
Shaul, M. E., & Fridlender, Z. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0222-4 · Cited by 1,023
Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer
Wouters, M. C. A., & Nelson, B. H. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1481 · Cited by 495
Immune infiltration in renal cell carcinoma
Zhang, S., Zhang, E., Long, J., Hu, Z., Peng, J., Liu, L., Tang, F., Li, L., Ouyang, Y., & Zeng, Z. (2019) · Cancer Science · doi:10.1111/cas.13996 · Cited by 305
Metadata
- Authors
- Liu, X., Wu, S., Yang, Y., Zhao, M., Zhu, G., & Hou, Z.
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 95
- Pages
- 55-61
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W2749042075
- Cited by
- 348
- References
- 36
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.